5/6 nephrectomy induces different renal, cardiac and vascular consequences in 129/Sv and C57BL/6JRj mice

被引:0
作者
Mouad Hamzaoui
Zoubir Djerada
Valery Brunel
Paul Mulder
Vincent Richard
Jérémy Bellien
Dominique Guerrot
机构
[1] Normandie Univ,Nephrology Department
[2] UNIROUEN,Pharmacology Department
[3] INSERM U1096,Biochemistry Department
[4] FHU REMOD-VHF,Pharmacology Department
[5] Rouen University Hospital,undefined
[6] Reims University Hospital,undefined
[7] Rouen University Hospital,undefined
[8] Rouen University Hospital,undefined
来源
Scientific Reports | / 10卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Experimental models of cardiovascular diseases largely depend on the genetic background. Subtotal 5/6 nephrectomy (5/6 Nx) is the most frequently used model of chronic kidney disease (CKD) in rodents. However, in mice, cardiovascular consequences of 5/6 Nx are rarely reported in details and comparative results between strains are scarce. The present study detailed and compared the outcomes of 5/6 Nx in the 2 main strains of mice used in cardiovascular and kidney research, 129/Sv and C57BL/6JRj. Twelve weeks after 5/6 Nx, CKD was demonstrated by a significant increase in plasma creatinine in both 129/Sv and C57BL/6JRj male mice. Polyuria and kidney histological lesions were more pronounced in 129/Sv than in C57BL/6JRj mice. Increase in albuminuria was significant in 129/Sv but not in C57BL/6JRj mice. Both strains exhibited an increase in systolic blood pressure after 8 weeks associated with decreases in cardiac systolic and diastolic function. Heart weight increased significantly only in 129/Sv mice. Endothelium-dependent mesenteric artery relaxation to acetylcholine was altered after 5/6 Nx in C57BL/6JRj mice. Marked reduction of endothelium-dependent vasodilation to increased intraluminal flow was demonstrated in both strains after 5/6 Nx. Cardiovascular and kidney consequences of 5/6 Nx were more pronounced in 129/Sv than in C57BL/6JRj mice.
引用
收藏
相关论文
共 75 条
[11]  
Schefold JC(2018)Genetic background influences cardiac phenotype in murine chronic kidney disease Nephrol. Dial. Transplant. 33 1129-19
[12]  
Filippatos G(2018)The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia PloS One 13 e0196684-1153
[13]  
Hasenfuss G(2018)Exogenous BMP7 in aortae of rats with chronic uremia ameliorates expression of profibrotic genes, but does not reverse established vascular calcification PloS One 13 e0190820-1264
[14]  
Anker SD(2016)Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy J. Cell. Mol. Med. 20 1106-2507
[15]  
von Haehling S(2010)Models of chronic kidney disease Drug Discov. Today Dis. Models 7 13-355
[16]  
Erdely A(2010)Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model Kidney Int. 78 1136-808
[17]  
Freshour G(2016)Selective Vascular Endothelial Protection Reduces Cardiac Dysfunction in Chronic Heart Failure Circ. Heart Fail. 9 e002895-374
[18]  
Tain Y-L(2012)Reduction of heart failure by pharmacological inhibition or gene deletion of protein tyrosine phosphatase 1B J. Mol. Cell. Cardiol. 52 1257-284
[19]  
Engels K(2006)Improvement of peripheral endothelial dysfunction by protein tyrosine phosphatase inhibitors in heart failure Circulation 114 2498-716
[20]  
Baylis C(2003)Model of robust induction of glomerulosclerosis in mice: importance of genetic background Kidney Int. 64 350-723